MBIO elevated OBVAs long as OBV can stay above 2.66 there's a chance for share price to return to that level.
0%
0%
0%
0%
0%
About Mustang Bio, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Manuel Litchman
Website
mustangbio.com
Headquarters
Worcester
Employees
113
Founded
2015
ISIN
US62818Q2030
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Quietly consolidating and might start movingFor the past 3 years its been trading in a nice zone while smart money's been loading up. MBIO has been working on some promising drugs. Inside buying has been goin gup and short interest has been coming down.
I think it's ready to move this year.
MBIOMID-TERM: At support, 4hr triple classic bullish divergence, daily hidden bullish divergence and oversold on RSI. (not financial advice)
Mustang Bio, Bullish BatBullish Bat on Mustang still has room to run. Fibonacci targets .382 @ $3.70 and .618 @ $4.20 🤑 Good luck traders
MUSTANG BIO inc weekly daily buy 4.06Mustang bio on weekly accumulation begins in april 2019 this green weekly candle put firm base and established accumulation levels by big players.
recent break above resistance ma . and two big green accumulation one after another. signaling that new uptrend may start soon.
On daily decline back
Beautiful long setup emerging.I have been watching this name since 2.5 and have been amazed by how much poised price action been since. Never too late get into to a working setup.
Love this small cap biotech stockSlightly sloppy structure on the daily but sometimes that's even more bullish. Thanks to Scott Redler for bringing this stock to my attention.
Weekly chart:
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
